Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial

Hiten D. Patel, Mohamad E Allaf

Research output: Contribution to journalArticle

Abstract

Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Erythropoietin Receptors
Recovery of Function
Prostatectomy
Erythropoietin
Prostatic Neoplasms
Placebos

ASJC Scopus subject areas

  • Urology

Cite this

@article{4a73852e11be420da7f0d5b9ab9dd4e8,
title = "Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: The ERECT Trial",
abstract = "Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.",
author = "Patel, {Hiten D.} and Allaf, {Mohamad E}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.euf.2018.01.002",
language = "English (US)",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy

T2 - The ERECT Trial

AU - Patel, Hiten D.

AU - Allaf, Mohamad E

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

AB - Erythropoietin receptors have been localized to human penile tissue and periprostatic neurovascular bundles. ERECT is a placebo-controlled, phase 2, randomized trial assessing the effect of erythropoietin on recovery of erectile function for men undergoing radical prostatectomy for prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=85040619396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040619396&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2018.01.002

DO - 10.1016/j.euf.2018.01.002

M3 - Article

C2 - 29373284

AN - SCOPUS:85040619396

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

ER -